Research protocols explore combination approaches with other senolytic compounds such as dasatinib and quercetin, providing frameworks for studying multi-target senolytic strategies and understanding synergistic effects in various experimental models and disease research applications
R.Dos SantosA
It is currently being evaluated in clinical trials
Despite inherent limitations of observational data and potential for residual confounding, the results from these observational analyses support, in line with RCT findings, combining SGLT2is and GLP-1RAs to reduce cardiovascular events in patients with diabetes in routine clinical care [12, 23, 43, 63]
Ten out of 10, like a red-hot poker burning through my right side, and I had to vomit my guts up for hours until there was nothing left
You can also browse our blog section for more in-depth guides